Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Trillions of SNPs Versus a Glass of Grappa

David S. Pisetsky, MD  |  Issue: April 2011  |  April 13, 2011

Although billions and billions is a daunting quantity, the reality of these studies are data sets with trillions and trillions points, or whatever 106 x 105 winds up to be (that’s the number of SNPs times the number of people tested). I have trouble keeping track of experiments with 96 wells in an ELISA plate or 12 lanes in a Western blot. No way could I manage the mass of data needed to harvest, as the geneticists put it, the low-hanging fruit, let alone the high-hanging fruit that a modern genome-wide association study makes possible.

I can just imagine a conversation like the following: ‘Well, Mr. Jones, we just ran your genome and we have good news and bad news. The good news is that you have a cytosine at position number 163 of your TNF gene. The bad news is that it is methylated.’ Good luck in explaining that one.

Benefits of Personalized Medicine?

As several of the speakers at the meeting stated, we are about to enter the era of personalized medicine in which science can predict the likelihood of disease for that part of etiology that is genetic in origin. Much of disease etiology is environmental and for that prediction is less good. Nevertheless, soon we can tell people about their risk for developing rheumatoid arthritis or lupus, assuming that they want to know. Risk profiles will likely only be relative, but such information could be valuable in planning strategies for prevention.

At this point in personalized medicine, things get uncertain because current strategies for disease prevention are limited and often difficult to implement. We all know that the arrows in the quiver of prevention are few: exercise, don’t smoke, don’t eat, and don’t drink (unless you are French, in which case you can guzzle the red stuff until you are 100). Alas, unless you want to stay hermetically sealed in a space suit, bugs of all kind will come your way and mess with your toll receptors, potentially stirring up the mischief known as inflammatory and autoimmune disease.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Hot on the heels of the genetic revolution is the epigenetic revolution. Epigenetics refers to the modification of genes, such as base methylation, which determines how genes are switched on and off. Thus, even if two individuals are genetically identical, changes in the epigenome may determine how heredity plays out to affect the risk for disease. Indeed, as one of the speakers at the meeting described, identical twins discordant for lupus show distinct patterns of base modification in their expressed genomes.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 | Single Page
Share: 

Filed under:OpinionResearch RheumRheuminationsSpeak Out RheumTechnology Tagged with:geneticsResearchrheumatologistTechnology

Related Articles

    A Unique Structure for Tackling Psoriatic Disease

    June 13, 2011

    GRAPPA brings together a group of highly motivated physicians to address these complex disorders

    Experts Discuss the Latest Precision Medicine Research

    February 18, 2018

    SAN DIEGO—In just two decades, precision medicine has gone from futuristic concept to realistic toolbox for clinical physicians. At the 2017 ACR Clinical Research Conference on Nov. 3, the Precision Medicine in Rheumatic Diseases: Hopes and Challenges lecture featured rheumatologists and experts on genetics, genomics, pharmaco­genetics and big data who spoke about the latest research…

    Gene Manipulation Has Potential to Alter Genomes, Impact Society

    Gene Manipulation Has Potential to Alter Genomes, Impact Society

    January 19, 2016

    Every so often, a major scientific breakthrough profoundly alters the trajectory of scientific research. In the 1960s, microbiologists sparked the recombinant-DNA revolution with the discovery that bacteria have innate immune systems based on restriction enzymes. These enzymes bind and cut invading viral genomes at specific short sequences, and scientists rapidly repurposed them to cut and…

    Genome-Wide Association Studies of SLE

    February 12, 2011

    What do these studies tell us about disease mechanisms in lupus?

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences